Study
is the first to examine effectiveness of sleep apnea treatment on high blood
pressure and diabetes control in a real-world setting.
A new study suggests that when prescribed by
physicians in routine practice and used appropriately by patients, treatment
for obstructive sleep apnea (OSA) could reduce blood pressure in men with
hypertension. “All types of patients may benefit from this treatment, even
those with other chronic medical conditions,” said Bharati Prasad, MD, MS, the
study’s principal investigator. “It’s important to now do a prospective study
enrolling different types of patients with sleep apnea.”
The study, appearing in the Oct. 15 issue of
the Journal of Clinical Sleep Medicine, examined the effectiveness of
obstructive sleep apnea treatment on high blood pressure and diabetes control
in 221 men with pre-existing hypertension or type 2 diabetes and a new
diagnosis of OSA. Participants received positive airway pressure (PAP) therapy
upon treatment initiation. Results show that both systolic and diastolic blood
pressure decreased significantly with initiation of OSA treatment at the first
follow-up, 3-6 months after initiation, and the second follow-up, 9-12 months
later.
According to the authors, this is the first
study to examine the effectiveness of treatment of obstructive sleep apnea on
routine measures of hypertension and diabetes control in a practice-based clinical
setting. The results show the real-world effectiveness of OSA treatment on
hypertension.
Red Orbit
No comments:
Post a Comment